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Object: We aimed to investigate the link between the autonomic nervous system (ANS) impairment, assessed using baroreflex sensitivity (BRS) and heart rate variability (HRV) indices, and mortality after aneurysmal subarachnoid haemorrhage (aSAH). 
Methods: A total of 57 patients (56 ± 18 years) diagnosed with aSAH were retrospectively enrolled in the study, where 25% of patients died in the hospital. Cerebral autoregulation (CA) was assessed using the mean velocity index (Mxa), where Mxa>0 indicates impaired CA. BRS was calculated using a modified cross–correlation method. Time– and frequency–domain HRV indices were calculated from a time–series of systolic peak intervals of arterial blood pressure signals.
Results: Both BRS and HRV indices were lower in non–survivors than in survivors. The patients with disturbed BRS and HRV had more extensive hemorrhage in the H–H scale (p=0.040) and were more likely to die (p=0.013) when compared to patients with the intact ANS. The logistic regression model for mortality included: the APACHE II score (p=0.002; OR 0.794) and the normalized high frequency power 
of the HRV (p<<0.001; OR 0.636). A positive relationship was found between the Mxa and BRS (R = 0.48, p=0.003), which suggests that increasing BRS is moderately strongly associated with worsening CA.
 Conclusion: Our results indicated that lower values of HRV indices and BRS correlate with mortality and that there is a link between cerebral dysautoregulation and the analysed estimates of the ANS in aSAH patients. 








Aneurysmal subarachnoid haemorrhage (aSAH) is a devastating condition with a high rate of mortality and morbidity. It has been shown in previous research that in patients with aSAH both neurological and cardiac abnormalities may occur, as a result of the interdependence between the central nervous system and the heart [1][2]. The mechanism, which reflects a complex integration between cardiovascular reflexes and the central nervous system, is the baroreflex [3]. In addition, another metric which has been shown to be a non–invasive indicator of autonomic nervous system (ANS) activity is the heart rate 
variability (HRV).
The arterial baroreflex plays an important role in neural cardiovascular regulation by the rapid and effective regulation of blood pressure through the activity of sympathetic and parasympathetic branches of the ANS [4]. The index, which assesses the reflex response from arterial baroreceptors, is called baroreflex sensitivity (BRS) [5]. Dysfunction of BRS has been shown to be associated with a poor long–term outcome after acute ischemic stroke [6] and intracerebral haemorrhage [7]. The HRV quantifies the interplay of the vagal and sympathetic outflow [8] and is a measure of the ANS and sinoatrial node’s response to environmental changes [9]. Reduced HRV has been reported in diabetes, ischemic heart diseases, and other cardiovascular disorders [10]. Moreover, HRV has been found to be an indicator of severity and outcome in neurological disorders and may predict delayed cerebral ischemia (DCI) in aSAH patients [11]. 
Although BRS and HRV disturbances are non–specific changes and have been found in several neurological and non–neurological diseases, their continuous, real–time assessment could provide important information in aSAH patients. The aim of this study was to investigate the relationship between ANS impairment, assessed using HRV indices and BRS, and mortality after aSAH. 
2.	Methods
2.1.	Setting
58 patients hospitalized between 2014 and 2017 with aSAH and managed in the Intensive Care Unit (ICU) were retrospectively analysed. All subjects were adults (age ≥18 years). 
The aneurysmal cause of bleeding was confirmed using computed tomography (CT). 
In the analysed cohort of patients there were no previously diagnosed cardiovascular diseases (cardiomyopathy, myocardial infarction, stroke, heart failure or heart arrhythmia) or neurological disease. 
2.2.	Patient treatment and management
All patients were treated according to the current guidelines from the American Heart Association/American Stroke Association [12]. The average length ± standard derivation of patient hospitalization was 27±22 days, with an average of 16±12 days in the ICU 
and 11±13 days in the neurosurgical ward. The decision to treat with surgical clipping or endovascular coiling was based on the patient’s condition and medical indications (intracranial hematoma, size, morphology and localisation of the aneurysm) and was the responsibility of the attending clinician. Aneurysm treatment was performed within 24 hours after admission. The treatment algorithm included euvolemia, analgesia, sedation and inotropic support when indicated. Depending on the indications, patients were either mechanically ventilated (bilevel positive airway pressure respiration with controlled respiratory mode, BiPAP) or they remained on passive oxygen therapy. DCI management included hypertensive therapy with mean arterial pressure targets. All patients received nimodipine [12]. In the ICU all patients were classified using the Glasgow Coma Scale (GCS), Acute Physiology and Chronic Health Evaluation II scale (APACHE II), and Full Outline of UnResponsiveness scale (FOUR). The Hunt and Hess (H–H) grading scale was used to classify the severity of aSAH. The Fisher scale was used to grade the blood load on the CT. Aneurysms were classified as small (1 mm–5 mm), medium (6 mm–10 mm), large (11 mm–24 mm) and giant (>= 25 mm). Short term–outcome was assessed with the Glasgow Outcome Scale (GOS) at discharge from the hospital. In the GOS scale, good results were classified as III–V and poor as I–II. 12–lead electrocardiogram (ECG) recordings were obtained in the hospital emergency department and then on following days of stay in the ICU when required. ECG abnormalities were defined as at least one of the following disturbances: prolongation of a corrected QT interval (QTc>460 ms in women, QTc>450 ms in men), elevation of the ST segment, a pathological Q wave, an inverted T wave and abnormal heart rate (HR) or arrhythmia. Neurophysical deficits or neuropsychological impairment refer to focal neurological impairment (aphasia, ataxia), cognitive dysfunction or weakness or paralysis in the arms and legs and were investigated daily through physical examination, which consisted of a standardised neurological examination. Cerebral vasospasm was defined as mean cerebral blood flow velocity (CBFV) in the middle cerebral artery (MCA) exceeding 120 cm/s in transcranial Doppler ultrasonography (TCD) or increasing velocity by ~20% [13] [14]. Cerebral delayed infarctions were determined using CT after excluding post–operative changes (within 24 hours of treatment). The DCI was defined as a new focal or global neurological impairment lasting for at least one hour and cerebral infraction not related to other causes (i.e. surgical complications) [15]. 
2.3.	Acquisition of data and signal processing
Signal monitoring was performed continuously during the patient’s stay in the ICU, starting in the first 24 hours after onset and continuously up to the discharge from the ICU 
or when medically required. The mean time of signal monitoring was 6 days. Arterial blood pressure (ABP) was recorded in continuous mode, whereas CBFV was monitored in patients for whom it was medically required for about half an hour per day (patient measurements were repeated at least twice in subsequent days). The ABP was measured invasively in the radial or femoral artery using a pressure transducer (Argon Standalone DTX Plus™, Argon Medical Devices Inc.Plano, Texas, USA). The CBFV in the MCA was monitored using TCD with a 2 MHz probe (Doppler BoxX, DWL Compumedics Germany GmbH, Singed, Germany). Data were digitized with an analog–digital converter and recorded with a sampling frequency of 200 Hz using the ICM+ system (Cambridge Enterprise Ltd, Cambridge, UK). Recorded signals were analysed using algorithms embedded in the ICM+ and MATLAB® (MathWorks®, Natick, Massachusetts, USA) software as well as custom–written scripts. Artefacts were selected and removed using customised algorithms or manually selected to prepare the signals for further analysis. 
2.4.	Heart rate variability
An analysis of HRV was performed in accordance with the standards described in the Task Force of the European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology [16]. Due to insufficient quality or unavailability of the electrocardiogram signal in some cases, HRV indices were calculated from the ABP signal using algorithms embedded in the ICM+ system. Ectopic beats were selected manually 
or automatically in the ICM+ and deleted. HRV indices were assessed based on the time series of systolic peak intervals in a calculation window of 300 seconds updated every 10 seconds. In the frequency domain the Lomb–Scargle periodogram [17] was used to determine the power spectral density of the interval time series in the low frequency range 
(LF, 0.04–0.15 Hz) and the high frequency range (HF, 0.15–0.40 Hz). In addition, total power of the HRV signal (TP, 0.04–0.40 Hz) and the ratio between low and high frequency components (LF/HF) were calculated. Normalized power of HF and LF components (HFn and LFn, respectively) were defined as the component’s power (HF or LF, respectively) divided by the TP. In the time domain the following metrics were determined: standard deviation of the sequential beats (SDNN) and the square root of the mean squared differences of successive sequential beats (RMSSD). HRV indices were determined as median values from the total monitoring time.
2.5.	Baroreflex sensitivity
The algorithm for the BRS calculation based on the sequential cross–correlation method proposed by Westerhof et al. [18] was embedded in ICM+. This method estimates BRS as the slope of the regression line between 10–second segments of the systolic peak–to–peak interval time series and the corresponding 10–second series of systolic pressure values calculated from the ABP signal with a delay of 0–5 seconds. Due to the unknown time delay between those two data series the cross–correlation function is applied to receive a maximum correlation coefficient with a significance level of 0.01. The BRS time course was calculated using a moving average window of 10 seconds and expressed in ms/mmHg. The median BRS was determined from the total monitoring time.
2.6.	Cerebral autoregulation assessment
Cerebral autoregulation (CA) was assessed using the mean velocity index (Mxa). The Mxa was calculated as the Pearson linear correlation coefficient between CBFV and ABP (averaged over 10–second intervals) in a 5–minute moving average window updated every 
10 seconds. The Mxa was determined as the median value from all the available CBFV recordings throughout the patient monitoring.
2.7.	Statistics 
Statistical analysis was performed using STATISTICA version 12 (StatSoft, Inc., Tulsa, USA). The data normality distribution was assessed using the Kruskal–Wallis test with the Lilliefors correction. Non–parametric tests were applied due to the rejection of the normality hypothesis for most of the analysed indices. The level of significance for all statistical tests 
was set at 0.05. The differences in median values of ANS and non–ANS indices, categorised by any dichotomised criteria defined in this study, were tested using the U Mann–Whitney test. Receiver operating curves (ROC) were used to determine discrimination cut-off values and the predictive power of disturbed ANS indices as predictors of mortality [19]. Optimal cut-off points were calculated using the Youden index method and the values of statistics for the area under the curve (AUC) were calculated using the DeLong method [20]. The Kaplan–Meier plot and Cox proportional hazards model with FCox statistics were used to assess differences in mortality in patients with disturbed and intact ANS indices. In the analysis of survival, patients who were alive were classified as censored observations, and the survival time consisted of the total time of hospitalisation (including time spent in the ICU and in the neurosurgical ward). Differences in the number of patients, categorised by any criteria defined in this study, were tested using a contingency table and the results were assessed based on 
a chi–square test (CHI2) with the Yates correction. The Spearman correlation was used to test the relationship between the Mxa and the corresponding BRS and HRV indices. Logistic regression was used to prepare a model for predicting mortality, using backward stepwise elimination [21]. The selection of significant ANS and non-ANS predictors was based on removal testing, which is dependent on the probability of the likelihood–ratio statistic. Statistical significance was assessed using the CHI2 test for the overall model and the CHI2 test for the log–likelihood ratio and Wald’s test statistics for the predictors. The accuracy of the model classification was measured by the ROC curve statistic. To evaluate the fit of the model, the Hosmer and Lemeshow (HL) test was applied (for the HL test, p<0.05 indicated poor model fit).
3.	Results
3.1.	Patient characteristics 
The basic clinical data of the analysed group are presented in Table 1. The median H–H grade was 3±1 and the median Fisher grade was 3±1 in a total group. The aneurysms were located either in the supratentorial region of the brain (43 subjects, 75%) or in the posterior (vertebro–basilar) circulation (14 subjects, 25%). 88% of subjects (n=50) had small aneurysms, 10% (n=6) had medium–sized aneurysms, and 2% (n=1) had a large aneurysm. DCI was seen in 20 patients (35%), while TCD diagnosed vasospasm was seen in 21 patients (37%). Delayed infarcts on the CT were seen in 32 patients (56%). 
3.2.	Data monitoring 
Exemplary time trends of recorded signals, BRS and selected HRV indices are presented in Supplementary Figure 1. The mean ± standard derivation of data availability, defined as 
a percentage of the total monitoring time were as follows: ABP 81.2%±25.5%, 
BRS 70.7%±26.8%, SDNN 77.7%±27.7%, RMSSD 77.7%±26.7%, LFn 82.9%±25.6%, 
HFn 82.9%±25.6%, LF/HF 82.2%±25.5%, TP 78.6%±25.1%. ABP was monitored in all 58 patients, whereas CBFV was monitored in 38 subjects. The median ± interquartile range 
of the ABP was 89.16±11.34 mmHg and CBFV was 47.97±23.84 cm/s, respectively.
3.3.	Surviving analysis based on BRS and HRV
In the analysed group fourteen patients (25%) died in the hospital. In all cases the cause 
of death was the direct effect of the primary haemorrhage. Of the survivors, 74% (n=42) had 
a good short–term outcome, whereas 26% (n=15) had a poor short–term outcome. 
The differences between the ANS indices in survivors vs. non–survivors are presented in Table 2. All the ANS indices except HF showed significant differences in survivors vs. non–survivors, see Table 2. The receiver operator characteristic curves (ROC) were used to determine the cut-off values of the BRS and HRV indices for predicting in–hospital mortality. The obtained cut–off values, with respective statistics which indicated disturbed ANS indices, are shown in Table 3. Subject was classified as patient with abnormal ANS if the median value of at least one of the ANS index was below the ROC curve-based cut-off value. Abnormal median values of HRV indices or BRS were observed in 40 patients (70% of the total group). Patients with disturbed ANS indices were more likely to die (14 subjects; 35% of that group) compared to patients with intact ANS indices (any death case) based on the contingency table (p=0.013). Both Kaplan–Meier plots (see Figures 1a–d) and the FCox test (see Table 3) indicated that the probability of survival is statistically lower in patients with disturbed ANS indices. 
3.4.	Clinical parameters versus disturbances in ANS indices
A comparison of clinical parameters in groups with and without disturbances in ANS indices is presented in Table 1. We observed that patients with a disturbed ANS had more extensive haemorrhage, based on the H–H grade and a worse FOUR score, than those with normal BRS and HRV indices: (4±1 vs. 3±1, p=0.040 for the H–H grade; 12±4 vs. 14±2, p=0.038 for the FOUR score). These patients required mechanical respiration (35 subjects; 88%) more frequently than ones with intact ANS indices (7 subjects; 41%), p=0.006 and they had previously diagnosed hypertension (22 patients, 55% vs. 5 patients, 29%), p=0.050. 
We found ECG disturbances both in patients with reduced HRV indices or BRS (40% of this group) and in those with intact ANS indices (59% of this group), see Table 1.
3.5.	Correlation between ANS indices and cerebral autoregulation 
In addition to the ANS indices obtained using long–term ABP monitoring, the Mxa was analysed based on the relatively short-time CBFV signal recording (see Supplementary 
Figure 2). The Mxa was calculated in 37 patients (65% of the whole group) and was significantly correlated with corresponding value of BRS (R=0.48, p=0.003), HF (R=0.53, p=0.0002), LF (R=0.47, p=0.003), TP (R=0.48, p=0.002), RMSSD (R=0.39, p=0.02), and SDNN (R=0.39, p=0.02), respectively. There was no relationship between the Mxa and either the HFn, LFn or the LF/HF. Furthermore, there were no statistically significant differences in the values of the Mxa between survivors (n=30; Mxa=0.04±0.11) vs. non-survivors 
(n=7; Mxa=0.06±0.10).

3.6.	Multiple logistic regression model to predict short–term mortality
The following variables were used as predictors of short–term mortality in a multiple linear logistic regression model; (non–ANS parameters): age, the application of mechanical ventilation and the mean duration of mechanical ventilation, hypertension, cerebral delayed infarctions, APACHE II, GCS, FOUR score, H–H grade, Fisher grade, and the Mxa; 
(ANS indices): BRS, LF, LFn, HF, HFn, TP, LF/HF, RMSSD, SDNN. The choice of predictive variables was carried out by an automatic procedure using backward stepwise elimination (Likelihood–ratio based, see the Statistics section). Among all possible predictors, the model including HFn, APACHE II and the mean duration of mechanical ventilation was found to be statistically significant (see Table 4). The model CHI2 statistic was 43.381 (p=0.00001). The obtained model had a good fit: HL=4.665, p=0.792. The model exhibited good discrimination ability based on the ROC curve statistic: AUC=0.970, p<<0.001.
4.	Discussion
The results from this study indicate that in aSAH patients with disturbed BRS and HRV indices mortality is significantly higher in subsequent days after onset than for patients with intact ANS indices. The relationship between abnormal BRS, HRV indices and mortality in aSAH patients is a new observation, which supports the previous findings about cerebrovascular and ANS dysfunction after aSAH [22][23]. 
Cardiac manifestations have been widely described in aSAH patients, and the cardiac disorders include ex. cardiac arrest, cardiac arrythmia, Takotsubo cardiomyopathy, elevations in serum cardiac enzymes, and ECG abnormalities (QTc intervals, T– wave and ST segments changes) [24]. It has been observed in clinical practise that aSAH may also lead to ANS dysfunction, caused by the release of inflammatory cytokines [25]. In our research, both the BRS and HRV indices, which are ANS measures, were significantly lower in non–survivors than in survivors with aSAH. Moreover, we found that patients diagnosed with hypertension had ANS disorders more often than subjects without hypertension (55% vs. 29%).
Our results indicate that patients with extensive haemorrhage, assessed with Fisher and 
H–H scales, had disturbed BRS and HRV indices more often than subjects with moderate aSAH. Currently, there is no conclusive hypothesis about the link between the extent of bleeding and ANS impairment. One possible explanation may be the negative impact of free blood around and within the brain on the control of the central nervous system, which could 
lead to sympathetic hyperactivity and a hyperadrenergic state [25]. An alternative hypothesis is that an aneurysm rupture may cause a rush in intracranial pressure, which via hypothalamus stimulation leads to an increase in the serum levels of catecholamines [25].
The HF reflects the parasympathetic activity of the ANS, corresponds to the respiratory cycle (respiratory sinus arrhythmia) [26] and is regulated by the vagus nerve via release 
of acetylcholine at the postganglionic muscarinic receptors [27]. The LF is assumed 
to express a sympathetic component [28], but it has been shown that LF may express baroreceptor activity rather than cardiac sympathetic innervation [29]. The complex physiological basis of the LF/HF ratio creates difficulties in interpretation. It has been shown that the LF/HF ratio may not reflect a simple sympatho–vagal balance, because of the non–linear character of the relationship between sympathetic and parasymaptehtic nerve activity, the interfering impact of respiration, and the mean HR as such, rather than ANS innervation activity [35]. The RMSSD and SDNN are basic metrics of variance and vagally mediated changes in HR; however, SDNN is less influenced by the parasympathetic nervous system than RMSSD. It has been hypothesised that low RMSSD reflects a poor vagus– mediated HRV, which may lead to increased susceptibility to cardiac dysfunction [36]. In the analysed group of aSAH patients a reduction of LF, LFn, HF, LF/HF, SDNN, RMSSD, and TP were observed, which indicates ANS dysfunction. More recent evidence shows that a significant reduction in LF, HF, and TP is correlated with increased mortality, brain death, and longer time to recover after TBI [30][31][32], which is in line with our observations in aSAH patients. Furthermore, it was found in previous research that the LF/HF ratio was lower in patients with poor GCS [33] and with intracranial haemorrhage after TBI [34].The observed elevation of HFn power may be related to the spontaneous hyperventilation observed in patients with significant neurological impairment, rather than ANS dysfunction as such. 
The multiple logistic regression model has shown that HFn is a better predictor of mortality after aSAH than the assessment of patient condition with the APACHE II scale (p<<0.001; OR 0.636; 95% CI 0.467–0.867 vs. p=0.002; OR 0.794; 95% CI 0.663–0.951). This observation proves the importance of ANS indices changes as prognostic factors in aSAH patients. However, it should be emphasized that the exact mechanism of how ANS disturbances affect outcome is still unknown. One hypothesis states that the increase in vagal tone (manifesting as a higher HFn) causes immunosuppressive effects via the cholinergic anti-inflammatory pathway [32].
In our study, increasing BRS was moderately associated with impaired CA, which implies an inverse relationship. However, a disturbed CA is reflected in the positive values of the Mxa – the higher the Mxa, the worse the CA. Therefore, the value of the Spearman correlation is positive. The correlation between the Mxa and BRS, LF, and TP are presented in Supplemental Figure 3. The observation about the inverse relationship between CA and BRS is in line with previous research [37]. Tzeng et al. reported that individual variations in BRS and CA are inversely correlated in healthy volunteers [38]. Furthermore, the results 
of a study performed on patients with hypertension and disturbed BRS showed that CA was preserved in this group of patients [39]. This is an indirect observation, which indicates that impaired BRS may be related to intact CA. It has been found that the physical explanation of an inverse relationship between ANS indices and CA in stroke patients may be from the compensation of one of the homeostatic mechanisms [38]. Another hypothesis stated that an increase in efferent sympathetic activity may cause the worsening of CA [37]. We are aware that another studies suggested that the relationship between CA and BRS may be rather direct than inverse [40]. However, those findings may have been the result of different methodologies used for assessing CA. We did not observe differences in the Mxa values between survivors vs. non-survivors, which might have been due to the limited number of patients with TCD measurements.
Although BRS is not routinely measured in clinical practise, mainly because of the large number of measurement methods and inconclusive evidence of its clinical usefulness [41], attempts are being made to apply BRS–targeted therapy [42]. In 2002 La Rovere, et al. [42] published the results of a study about exercise–induced increases in BRS in post–myocardial infraction patients. The study showed that cardiac mortality was significantly lower in exercised subjects with higher BRS than in non–exercised ones [42]. Another study from 2015 conducted in a randomized cohort of 140 patients with ejection heart failure showed that patients who received medical therapy alone had worse recovery and outcome than subjects with medical therapy combined with baroreflex activation therapy (BAT) [43]. BAT has been successfully applied as a supplement to pharmacological treatment and found as an approach that improves outcome in patients with resistant hypertension [44] and chronic heart failure [45].
Our results show that disturbances in HRV indices and BRS are related to higher mortality after aSAH. However, it must be emphasised that patient mortality and morbidity after aSAH depend on multiple factors, such as the general condition of the patient before onset, severity of the initial bleeding, and post–aSAH complications (hydrocephalus, vasospasm, DCI, infections) [46][47]. Therefore, BRS and HRV indices assessment in aSAH patients should be interpreted along with other clinical prognostic factors.
4.1.	Limitations
In order to investigate the relationship between BRS, HRV indices, and mortality of aSAH patients we chose to use not only selected parts of recorded signals, but the entire long–term data available. We are aware that various factors may have an impact on ANS indices like body position, temperature, sedation and analgesia, drugs, mechanical respiration and using respiratory strategies [48]. 
In our research we decided to analyse the ANS indices in both mechanically ventilated patients (42 subjects) and in passive-oxygen supported patients (15 cases). We want to emphasise that the mean duration of mechanical ventilation varied between subjects. We analysed the changes in BRS and HRV indices throughout the entire monitoring time, which in most cases was longer than the mean duration of mechanical ventilation. Furthermore, the exact impact of the mechanical ventilation mode on cardioventilatory coupling and respiratory sinus arrhythmia (RSA), which is reflected as BRS and HRV modulation, is still not well-known [49]. It has been shown that during controlled mechanical ventilation RSA could decrease significantly [50], whereas other research demonstrated that RSA was preserved [51]. Additional analysis (not presented in this paper) has shown that for mechanically ventilated patients (42 subjects), our main finding is preserved that the ANS indices are significantly lower in non-survivors than in survivors.
It is known that the anaesthetics used in general anaesthesia and inotropic agents may depress the ANS. In the analysed group of aSAH patients, subjects were sedated using propofol as the main drug. It has been shown that propofol causes a decrease in ABP due to the vasodilatory effect; however, it does not affect HR. [52] [53]. 48 patients (85%) were treated with catecholamines and/or positive inotropic agents. It was found that catecholamines did not significantly affect the BRS [54]. Furthermore, the analysis of patients with and without catecholamines may have provided misleading results due to the limited number of patients. We analysed the changes in the ANS indices over time, which in most cases was longer than the ‘biased’ period of the effect of administering the anaesthetic drugs. Because of the life-threatening conditions that occur after aSAH, the fraction of aSAH patients treated without any catecholamines and without anaesthetic drugs is very limited. Therefore, research conducted in a drug-homogenous group of patients seems to be a more adequate approach than excluding patients on inotropic drugs or sedatives, which are inherent agents in the ICU. However, further multiple–centre analysis needs to be done to examine the impact of anaesthesia and the inotropic agents on BRS and HRV indices as mortality predictors.
The availability of recorded signals at about 80% of the study duration is typical for the ICU environment because of treatment requirements and nursing procedures, and was similar in previously reported studies [32]. The reduced availability of BRS values to 71% is related to the restrictions of the algorithm, which excludes distorted and artificial fluctuations in the ABP signal. This research was a preliminary study about ANS disturbances and their relationship to mortality and CA and was conducted on a limited group of aSAH patients. Therefore, to generalize the results of this study for the entire population, a larger study involving more patients from different medical centres would be required. 
5.	Conclusion 
Our results indicate that dysfunction of the ANS after aSAH, as reflected by disturbed BRS and HRV indices, may lead to increased mortality. Continuous and long–term monitoring of BRS and HRV indices in aSAH, combined with CA monitoring of patients, may provide additional predictive information on aSAH patients.
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Table 1. Patient characteristics. All values are shown as N (% of the total group or % of the group with disturbed/intact autonomic nervous system (ANS) indices) or the median ± interquartile range.
	Total group	Patients with disturbed ANS indices	Patients withintact ANS 
indices	p–value
Demographic data
Subjects(including women)	57 (38)	40 (24)	17 (14)	––
Age [years]	56 ± 18	57 ± 14	58 ± 14	n.s.*
Hypertension	27 (47%)	22 (55%)	5 (29%)	0.050#
Smoking	31 (54%)	23 (58%)	8 (47%)	n.s.#
Assessment of patient condition at admission to the hospital
APACHE II	14 ± 9	16 ± 11	11 ± 7	n.s.*
GCS	11 ± 7	13 ± 8	14 ± 3	n.s.*
FOUR	12 ± 4	12 ± 4	14±2	0.038*
Assessment of the extent of aSAH
Fisher grade	3 ± 1	3 ± 1	3 ± 1	n.s.*
2, N	11 (19%)	8 (20%)	3 (18%)	n.s.#
3, N	15 (26%)	8 (20%)	7 (41%)	n.s.#
4, N	31 (55%)	24 (60%)	7 (41%)	0.030#
H–H grade	3 ± 1	4 ± 1	3 ± 1	0.040*
1, N	8 (14%)	4 (10%)	4 (24%)	n.s.#
2, N	9 (16%)	4 (10%)	5 (29%)	n.s.#
3, N	15 (26%)	12 (30%)	3 (18%)	0.038#
4, N	13 (23%)	10 (25%)	3 (18%)	n.s.#
5, N	12 (21%)	10 (25%)	2 (11%)	n.s.#
Treatment
Embolization	28 (49%)	17 (43%)	11 (65%)	n.s.#




Mean duration of mechanical ventilation[hours]	135.09	139.45	115.90	n.s.*
Complications
ECG disturbances	26 (46%)	16 (40%)	10 (59%)	n.s.#
Cerebral vasospasm	21 (37%)	16 (40%)	5 (29%)	n.s.#
Neurophysical deficits or neuropsychological impairment	27 (47%)	18 (45%)	9 (53%)	n.s.#
Cerebral delayed infarctions	32 (56%)	26 (65%)	6 (35%)	0.037#
DCI	20 (35%)	16 (40%)	4 (24%)	n.s.#
Abbreviations: APACHE II−Acute Physiology and Chronic Health Evaluation II, GCS−Glasgow Coma Scale, FOUR−Full Outline of UnResponsiveness scale, H–H−Hunt and Hess scale, 









SDNN [ms]	20.48 (18.28)	22.29 (18.90)	12.44 (14.44)	0.005
RMSSD [ms]	20.44 (18.24)	22.26 (18.86)	12.42 (14.41)	0.005
LF [ms2]	203.80 (296.57)	261.85 (419.50)	77.13 (129.66)	0.037
LFn [%]	17.77 (8.79)	18.56 (6.74)	11.45 (14.76)	0.002
HF [ms2]	154.40 (271.20)	166.30 (335.71)	80.99 (22.11)	n.s.
HFn [%]	18.43 (15.03)	15.19 (9.45)	29.97 (10.81)	<<0.001
LF/HF [a.u.]	1.18 (1.01)	1.36 (0.80)	0.42 (0.63)	<<0.001
TP [ms2]	960.25 (2009.00)	1321.50 (2030.30)	200.93 (467.07)	0.0001
BRS [ms/mmHg]	5.93 (5.11)	6.71 (5.07)	2.37 (5.06)	0.004
Abbreviations: HRV – heart rate variability, SDNN − standard deviation of the sequential beats of the HRV, RMSSD − square root of the mean squared differences of successive sequential beats of the HRV, LF – power of the HRV in the low frequency range, LFn – normalised power of the HRV in the low frequency range, HF – power of the HRV in the high frequency range, HFn − normalised power of the HRV in the high frequency range, LF/HF  − ratio between low and high frequency components of the HRV, TP − total power of the HRV, BRS − baroreflex sensitivity


Table 3.  The results of the receiver operating curve (ROC) statistics and surviving analysis 
(FCox test) used to determine the discrimination cut-off values and predictive power of disturbed autonomic nervous system (ANS) indices as predictors of mortality.
ANS index	ROC curve statistics	Surviving analysis














Table 4. Multiple logistic regression model to predict mortality in aneurysmal subarachnoid haemorrhage (aSAH) patients.

Parameter	CHI2 for 
log–likelihood ratio	p–value	Wald’s statistic	p–value	OR ratio	95% CI
HFn [%]	26.59	<<0.001	8.19	0.004	0.636	0.467–0.867
APACHE II [a.u.]	9.72	0.002	6.30	0.012	0.794	0.663–0.951
Mean duration of mechanical ventilation 
[hours]	4.21	0.040	2.77	0.096	0.986	0.970–1.002




Supplemental Figure 1 An example of the multimodal monitoring of a 67–year old woman 2 days after aneurysmal subarachnoid haemorrhage (aSAH) from a ruptured aneurysm in the internal carotid artery (ICA). ABP – arterial blood pressure, BRS – baroreflex sensitivity, LF – power of heart rate variability (HRV) in the low frequency range, SDNN − standard deviation of the sequential beats, LF/HF – ratio between low and high frequency components of the HRV.
Supplemental Figure 2 An example of the short–term monitoring of a 67–year old woman 2 days after aneurysmal subarachnoid haemorrhage (aSAH) from a ruptured aneurysm in the internal carotid artery (ICA). ABP – arterial blood pressure, BRS – baroreflex sensitivity, CBFV – cerebral blood flow velocity, Mxa – mean velocity index; the Mxa below 0 is interpreted as normal and above 0 as pathological.

Supplemental Figure 3 The Spearman correlation between median values of the mean velocity index (Mxa) and: a) baroreflex sensitivity (BRS), b) power of the heart rate variability (HRV) in the low frequency range (LF) and c) total power (TP) of HRV in a group of 57 patients with aneurysmal subarachnoid haemorrhage (aSAH).
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